Skip to main content

Bernocchi Perry A's Form 4 filing

Accendra Health IncACH · filed Nov 22, 2023

Accession no.
0001062993-23-021402
Filed
Nov 22, 2023
Trade date
Nov 22, 2023
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $361.9K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bernocchi Perry ACIK 0001967402Officer (EVP, CEO,. Patient Direct)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 22, 2023Common StockSSaleDisposed−19,302$18.75F2−$361,912.5164,347Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Weighted average of the sale price range of $18.61 - $19.38.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)